8-K ·Filed May 13, 2026

PVLA

PALVELLA THERAPEUTICS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001193125-26-220607
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor for any subsequent filings that may indicate why the company pursued this upgrade (e.g., upcoming capital markets activity or institutional investor requirements). No immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
PVLA ▲ +30.85% at T+60d
NEUTRAL call ✓ call won +30.85% · α vs SPY +26.42% · entry $120.57 → $157.77
Entry anchored
May 12, 03:59 PM ET
via exchange tick
T+1d
-1.33%
call -1.33% · α -2.10%
$118.97
settled 5mo ago
T+5d
-9.43%
call -9.43% · α -8.27%
$109.20
settled 5mo ago
T+20d
-11.77%
call -11.77% · α -11.16%
$106.38
settled 4mo ago
T+60d
+30.85%
call +30.85% · α +26.42%
$157.77
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Palvella Therapeutics received approval from Nasdaq to transfer its common stock listing from the Nasdaq Capital Market to the Nasdaq Global Market, effective May 13, 2026. The ticker symbol PVLA remains unchanged. This is an administrative listing upgrade with no financial impact.

Key Facts

  • Nasdaq approved transfer from Capital Market to Global Market on May 11, 2026
  • Transfer effective at open of business on May 13, 2026
  • Ticker symbol PVLA unchanged

Financial Impact

No financial figures disclosed; administrative listing tier change only

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-220607
Document: 0001193125-26-220607-index-headers.html0001193125-26-220607
Document: 0001193125-26-220607-index.html0001193125-26-220607
Document: 0001193125-26-220607.txt0001193125-26-220607
24 reports for PVLA
Performance horizon
67% Hit rate 4 of 6 directional calls best @ T+60▲ +35.07%May 15, 2026
Filters
Rows
Reports for PVLA — sortable, filterable
TypeNow
Sep 2, 2026
4w ago
144
NEUTRAL ★ 2/10
$155.47 $132.47▼ −14.79%▼ −13.61%$132.47 (−14.79%)
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 6/10
$152.22 $157.00▲ +3.14%▲ +4.05%$132.47 (−12.97%)
Aug 4, 2026
8w ago
8-K
NEUTRAL ★ 5/10
$151.99 $150.55▼ −0.95%▲ +0.29%$132.47 (−12.84%)
Jul 30, 2026
9w ago
Press Release
NEUTRAL ★ 2/10
$150.19 $150.33▲ +0.09%▼ −3.87%$132.47 (−11.80%)
Jul 28, 2026
9w ago
Press Release
NEUTRAL ★ 2/10
$142.84 $148.24▲ +3.78%▲ +0.40%$132.47 (−7.26%)
Jun 30, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$152.82 $141.77▼ −7.23%▼ −6.20%$132.47 (−13.32%)
Jun 22, 2026
14w ago
Press Release
BULLISH ★ 7/10
$118.84 $157.24▲ +32.31%▲ +32.46%$132.47 (+11.47%)
Jun 16, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$110.12 $149.68▲ +35.92%▲ +35.72%$132.47 (+20.30%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 3/10
$106.38 $151.04▲ +41.98%▲ +40.09%$132.47 (+24.53%)
May 15, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$114.24 $116.51▲ +1.99%▼ −0.13%$132.47 (+15.96%)
Showing 10 of 24

US Market Status

Market Closed — Opens Mon (63h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access